期刊文献+

阻塞性睡眠呼吸暂停低通气综合征患者血清心型脂肪酸结合蛋白和高敏C反应蛋白的变化及意义 被引量:5

Changes and implication of serum heart type fatty acid binding protein,high-sensitivity C-reactive protein in patients with obstructive sleep apnea hypopnea syndrome
下载PDF
导出
摘要 目的探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者血清心型脂肪酸结合蛋白(h-fabp)和超敏C反应蛋白(hsCRP)的表达水平及意义。方法选择经多导睡眠仪监测确诊的42例OSAHS患者(OSAHS组)和健康自愿者30例(对照组),采用酶联免疫吸附测定(ELISA)法检测两组血清h-fabp、hsCRP的表达水平,同时常规检测血清天冬氨酸转氨酶(AST)、肌酸激酶(CK)的水平。结果OSAHS组与对照组比较血清h-fabp的水平(11.73±3.45)μg/L vs(7.79±2.84)μg/L;hsCRP(5.41±1.83)mg/L vs(2.49±0.75)mg/L,差异均有统计学意义(均P<0.01);OSAHS组血清AST、CK水平与对照组比较差异无统计学意义(均P>0.05);OSAHS组h-fabp与呼吸暂停低通气指数(AHI)无相关性(r=0.246,P>0.05),而hsCRP与AHI呈正相关(r=0.656,P<0.01)。结论h-fabp、hsCRP联合检测与传统的心肌损害指标相比,对OSAHS患者发生心肌损害和未来心血管事件可能具有更高的预测价值。 Objective To explore the changes and implication of serum heart type fatty acid binding protein (h-fabp) ,high-sensitivity C-reactive protein (hsCRP) in patients with obstructive sleep apnea hypopnea syndrome (()SAHS). Methods 42 patients with OSAHS (OSAHS group) were selected by polysomnograshy(PSG) test and 30 healthy subjects(control group) were included. The levels of h-fabp, hsCRP were detected by ELISA, while serum creatine kinase(CK),aspartate transaminase(AST) were detected with regular methods. Results The levels of serum h-fabp,hsCRP in OSAHS group and control group were of statistic difference,(11. 73±3.45)ug/L vs (7.79±2.84) ug/L,(5.41±1.83) mg/L vs (2.49±0.75) mg/L both (both P〈0.01). No significant difference was found in serum AST,CK between OSAHS group and control group (both P 〉0.05). Serum h-fabp level in patients with OSAHS did not correlate significantly with apnea-hypopnea index(AHI) ( r = 0. 246, P 〉0.05), but hsCRP correlated positively with AHI( r = 0. 656, P 〈 0.01 ). Conclusion In comparison with traditional test indices for myocardial damages, combined test on serum h-fabp and hsCRP are of more important values in predicting the likelihood of the myocardial damages and future cardiovascular events in OSAHS.
出处 《临床荟萃》 CAS 2009年第16期1402-1405,共4页 Clinical Focus
关键词 睡眠呼吸暂停综合征 脂肪酸结合蛋白质类 C反应蛋白质 sleep apnea syndromes fatty acid-binding proteins C-reactive protein
  • 相关文献

参考文献14

  • 1McNichola WT, Bonsignore MR. Sleep apnoea independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities [J]. Eur Respir,2007,29(1) : 156-178.
  • 2中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(草案)[J].中华结核和呼吸杂志,2002,25(4):195-198. 被引量:1845
  • 3Bradley TD. Floras JS. Sleep apnea and heart failure. Part Ⅰ: obstructive sleep apnea[J]. Circulation, 2003,107 (12) : 1671- 1678.
  • 4Maekawa M, Shiomi T. Sleep apnea syndrome (SAS) and ischemic heart disease(1HD) [J]. Nippon Rinsho, 2000,58 (8) : 1702-1706.
  • 5Alhadi HA, Fox KA. Do we need additional markers of myocyte necrosis: the potential value of heart fatty acid binding protein[J]. Q J Med,2004,97(4) : 187-198.
  • 6Nakata T, Hashimoto A, Hase M, et al. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome[J]. Cardiology, 2003, 99 (2) :96-104.
  • 7Chu WW,Dieter RS,Stone CK. A review of clinically relevant cardiac biochemical markers[J]. Wis Med. 2002,101 (3):40- 48.
  • 8Keiichi T, Masatoshi F, shoichi M, et al. Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein(H-FABP) is an indicator of severe myocardial ischemia[J]. Cardiology, 2004,93 (2) :281-284.
  • 9Burcu O, Erdem A, Hikmet F, et al. Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome[J]. Sleep Breath, 2008,12 ( 3 ) : 223-228.
  • 10Patel VB,Robbins MA,Topoi EJ. C-reactive protein:a "golden marker" for inflammation and coronary artery disease[J]. Cleve Clin J Med,2001,68 (6):521-534.

二级参考文献10

共引文献1846

同被引文献87

  • 1王鹏举,刘灵文,罗鸿,肖虹,曹红,余晔.阻塞性睡眠呼吸暂停低通气综合征患者的血清瘦素水平[J].中华耳鼻咽喉头颈外科杂志,2005,40(4):243-246. 被引量:13
  • 2朱红秋,朱平安,沈双宏,汪润,赵毅.高敏C反应蛋白和心型脂肪酸结合蛋白对不稳定性心绞痛患者心脏意外事件的影响[J].中华心血管病杂志,2006,34(9):808-811. 被引量:49
  • 3敖华飞,郭竹英,高尚.阻塞性睡眠呼吸暂停低通气综合征病人手术前后血中炎性因子的变化[J].中国耳鼻咽喉颅底外科杂志,2006,12(5):368-370. 被引量:15
  • 4Yaggi HK, Concam J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death[J]. N Engl J Med, 2005,353(19) : 2034-2041.
  • 5Shamsuzzaman AS, Gersh BJ,Somers VK. Obstructive sleep apnea :implications for cardiac and vascular disease[J]. JAMA, 2003,290(14) :1906-1941.
  • 6Casas JP,Shah T, Hingorani AD, et al. C-reactive protein and coronary heart disease :a critical review[J]. J Intern Med, 2008,264(4) :295-314.
  • 7Sharma SK, Mishra HK, Sharma H, et al. Obesity, and not obstructive sleep apnea,is responsible for increased serum hsCRP levels in patients with sleep-disordered breathing in Delhi [J]. Sleep Med,2008,9(2) :149-156.
  • 8Shamsuzzaman AS, Winnicki M, Lanfranehi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea[J]. Circulation, 2002,105 (21 ) : 2462-2464.
  • 9Kang PM, Haunstetter A, Aoki H, et al. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation [J]. Circ Res, 2000,87 ( 2 ) :118-125.
  • 10Kasasbeh E, Chi DS, Krishnaswamy G. Inflammatory aspects of sleep apnea and their cardiovascular consequences[J].South Med J,2006,99(1):58-67.

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部